3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Myeloid
1
Conditions
Neoplasms
5
Multiple Myeloma
3
Hematologic Neoplasms
3
Thyroid Cancer, Papillary
2
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Melanoma
2
Lymphoma, Non-Hodgkin
2
Erdheim-Chester Disease
2
Carcinoma, Non-Small-Cell Lung
2
Xanthogranuloma, Juvenile
1
Thyroid Carcinoma, Anaplastic
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Lymphoproliferative Disorders
1
Laryngeal Neoplasms
1
Histiocytosis, Sinus
1
Histiocytosis, Langerhans-Cell
1
Histiocytic Sarcoma
1
Histiocytic Disorders, Malignant
1
Glioma
1
Colorectal Neoplasms
1
Adenocarcinoma, Follicular
1
Interventions
trametinib
1
dabrafenib
1
cobimetinib
1
Specimen Handling
1
Magnetic Resonance Spectroscopy
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Histiocytosis, Langerhans-Cell
×
cobimetinib
×
Clear all
NCT04079179
2025-09-18
NACHO-COBI
Baylor College of Medicine
Phase 2
Recruiting
90 enrolled